Erythroblastosis: the potential for eradication.
D000917:Antibody Formation; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D014481:United States
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System